Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

20.45
Delayed Data
As of 1:40pm ET
 +0.04 / +0.20%
Today’s Change
14.27
Today|||52-Week Range
22.83
+27.26%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close20.41
Today’s open20.46
Day’s range20.35 - 20.58
Volume267,330
Average volume (3 months)617,608
Market cap$5.2B
Dividend yield2.54%
Data as of 1:40pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.02%
Revenue growth (last year)+2.94%
P/E ratio--
Price/Sales2.46
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.12+0.39%
PTHNPatheon NV+0.01+0.03%
VRXValeant Pharmaceutic...+0.08+0.52%
UTHRUnited Therapeutics ...-0.55-0.42%
Data as of 1:57pm ET, 08/23/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Executive Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts